Click for best price
Angiotensinogen Monoclonal Antibody Market Size, Share 2024
The global Angiotensinogen Monoclonal Antibody market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Recombinant Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Angiotensinogen Monoclonal Antibody include Sino Biological, Inc., Elabscience Biotechnology Inc., Wuhan Fine Biotech Co., Ltd., Biomatik, MyBiosource, Inc., Assay Genie, Abbexa, Biorbyt and RayBiotech, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Angiotensinogen Monoclonal Antibody is an unconjugated antibody to Angiotensinogen.
This report aims to provide a comprehensive presentation of the global market for Angiotensinogen Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensinogen Monoclonal Antibody. This report contains market size and forecasts of Angiotensinogen Monoclonal Antibody in global, including the following market information:
Global Angiotensinogen Monoclonal Antibody Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Angiotensinogen Monoclonal Antibody Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Angiotensinogen Monoclonal Antibody companies in 2023 (%)
We surveyed the Angiotensinogen Monoclonal Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiotensinogen Monoclonal Antibody Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Angiotensinogen Monoclonal Antibody Market Segment Percentages, by Type, 2023 (%)
Recombinant
Non-recombinant
Global Angiotensinogen Monoclonal Antibody Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Angiotensinogen Monoclonal Antibody Market Segment Percentages, by Application, 2023 (%)
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Other
Global Angiotensinogen Monoclonal Antibody Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Angiotensinogen Monoclonal Antibody Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiotensinogen Monoclonal Antibody revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Angiotensinogen Monoclonal Antibody revenues share in global market, 2023 (%)
Key companies Angiotensinogen Monoclonal Antibody sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Angiotensinogen Monoclonal Antibody sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sino Biological, Inc.
Elabscience Biotechnology Inc.
Wuhan Fine Biotech Co., Ltd.
Biomatik
MyBiosource, Inc.
Assay Genie
Abbexa
Biorbyt
RayBiotech, Inc.
ZodelBiotec Ltd.
Innovative Research
Outline of Major Chapters:
Chapter 1: Introduces the definition of Angiotensinogen Monoclonal Antibody, market overview.
Chapter 2: Global Angiotensinogen Monoclonal Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of Angiotensinogen Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Angiotensinogen Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Angiotensinogen Monoclonal Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Angiotensinogen Monoclonal Antibody Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Angiotensinogen Monoclonal Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Angiotensinogen Monoclonal Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Angiotensinogen Monoclonal Antibody Overall Market Size
2.1 Global Angiotensinogen Monoclonal Antibody Market Size: 2023 VS 2030
2.2 Global Angiotensinogen Monoclonal Antibody Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Angiotensinogen Monoclonal Antibody Sales: 2019-2030
3 Company Landscape
3.1 Top Angiotensinogen Monoclonal Antibody Players in Global Market
3.2 Top Global Angiotensinogen Monoclonal Antibody Companies Ranked by Revenue
3.3 Global Angiotensinogen Monoclonal Antibody Revenue by Companies
3.4 Global Angiotensinogen Monoclonal Antibody Sales by Companies
3.5 Global Angiotensinogen Monoclonal Antibody Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Angiotensinogen Monoclonal Antibody Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Angiotensinogen Monoclonal Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 Angiotensinogen Monoclonal Antibody Players in Global Market
3.8.1 List of Global Tier 1 Angiotensinogen Monoclonal Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 Angiotensinogen Monoclonal Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Angiotensinogen Monoclonal Antibody Market Size Markets, 2023 & 2030
4.1.2 Recombinant
4.1.3 Non-recombinant
4.2 By Type - Global Angiotensinogen Monoclonal Antibody Revenue & Forecasts
4.2.1 By Type - Global Angiotensinogen Monoclonal Antibody Revenue, 2019-2024
4.2.2 By Type - Global Angiotensinogen Monoclonal Antibody Revenue, 2025-2030
4.2.3 By Type - Global Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
4.3 By Type - Global Angiotensinogen Monoclonal Antibody Sales & Forecasts
4.3.1 By Type - Global Angiotensinogen Monoclonal Antibody Sales, 2019-2024
4.3.2 By Type - Global Angiotensinogen Monoclonal Antibody Sales, 2025-2030
4.3.3 By Type - Global Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
4.4 By Type - Global Angiotensinogen Monoclonal Antibody Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Angiotensinogen Monoclonal Antibody Market Size, 2023 & 2030
5.1.2 Flow Cytometry
5.1.3 ELISA
5.1.4 Western Blot
5.1.5 Immunoprecipitation
5.1.6 Immunofluorescence
5.1.7 Other
5.2 By Application - Global Angiotensinogen Monoclonal Antibody Revenue & Forecasts
5.2.1 By Application - Global Angiotensinogen Monoclonal Antibody Revenue, 2019-2024
5.2.2 By Application - Global Angiotensinogen Monoclonal Antibody Revenue, 2025-2030
5.2.3 By Application - Global Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
5.3 By Application - Global Angiotensinogen Monoclonal Antibody Sales & Forecasts
5.3.1 By Application - Global Angiotensinogen Monoclonal Antibody Sales, 2019-2024
5.3.2 By Application - Global Angiotensinogen Monoclonal Antibody Sales, 2025-2030
5.3.3 By Application - Global Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
5.4 By Application - Global Angiotensinogen Monoclonal Antibody Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Angiotensinogen Monoclonal Antibody Market Size, 2023 & 2030
6.2 By Region - Global Angiotensinogen Monoclonal Antibody Revenue & Forecasts
6.2.1 By Region - Global Angiotensinogen Monoclonal Antibody Revenue, 2019-2024
6.2.2 By Region - Global Angiotensinogen Monoclonal Antibody Revenue, 2025-2030
6.2.3 By Region - Global Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
6.3 By Region - Global Angiotensinogen Monoclonal Antibody Sales & Forecasts
6.3.1 By Region - Global Angiotensinogen Monoclonal Antibody Sales, 2019-2024
6.3.2 By Region - Global Angiotensinogen Monoclonal Antibody Sales, 2025-2030
6.3.3 By Region - Global Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Angiotensinogen Monoclonal Antibody Revenue, 2019-2030
6.4.2 By Country - North America Angiotensinogen Monoclonal Antibody Sales, 2019-2030
6.4.3 US Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.4.4 Canada Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.4.5 Mexico Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Angiotensinogen Monoclonal Antibody Revenue, 2019-2030
6.5.2 By Country - Europe Angiotensinogen Monoclonal Antibody Sales, 2019-2030
6.5.3 Germany Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.5.4 France Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.5.5 U.K. Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.5.6 Italy Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.5.7 Russia Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.5.8 Nordic Countries Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.5.9 Benelux Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Angiotensinogen Monoclonal Antibody Revenue, 2019-2030
6.6.2 By Region - Asia Angiotensinogen Monoclonal Antibody Sales, 2019-2030
6.6.3 China Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.6.4 Japan Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.6.5 South Korea Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.6.6 Southeast Asia Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.6.7 India Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Angiotensinogen Monoclonal Antibody Revenue, 2019-2030
6.7.2 By Country - South America Angiotensinogen Monoclonal Antibody Sales, 2019-2030
6.7.3 Brazil Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.7.4 Argentina Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Angiotensinogen Monoclonal Antibody Sales, 2019-2030
6.8.3 Turkey Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.8.4 Israel Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.8.5 Saudi Arabia Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
6.8.6 UAE Angiotensinogen Monoclonal Antibody Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Company Summary
7.1.2 Sino Biological, Inc. Business Overview
7.1.3 Sino Biological, Inc. Angiotensinogen Monoclonal Antibody Major Product Offerings
7.1.4 Sino Biological, Inc. Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.1.5 Sino Biological, Inc. Key News & Latest Developments
7.2 Elabscience Biotechnology Inc.
7.2.1 Elabscience Biotechnology Inc. Company Summary
7.2.2 Elabscience Biotechnology Inc. Business Overview
7.2.3 Elabscience Biotechnology Inc. Angiotensinogen Monoclonal Antibody Major Product Offerings
7.2.4 Elabscience Biotechnology Inc. Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.2.5 Elabscience Biotechnology Inc. Key News & Latest Developments
7.3 Wuhan Fine Biotech Co., Ltd.
7.3.1 Wuhan Fine Biotech Co., Ltd. Company Summary
7.3.2 Wuhan Fine Biotech Co., Ltd. Business Overview
7.3.3 Wuhan Fine Biotech Co., Ltd. Angiotensinogen Monoclonal Antibody Major Product Offerings
7.3.4 Wuhan Fine Biotech Co., Ltd. Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.3.5 Wuhan Fine Biotech Co., Ltd. Key News & Latest Developments
7.4 Biomatik
7.4.1 Biomatik Company Summary
7.4.2 Biomatik Business Overview
7.4.3 Biomatik Angiotensinogen Monoclonal Antibody Major Product Offerings
7.4.4 Biomatik Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.4.5 Biomatik Key News & Latest Developments
7.5 MyBiosource, Inc.
7.5.1 MyBiosource, Inc. Company Summary
7.5.2 MyBiosource, Inc. Business Overview
7.5.3 MyBiosource, Inc. Angiotensinogen Monoclonal Antibody Major Product Offerings
7.5.4 MyBiosource, Inc. Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.5.5 MyBiosource, Inc. Key News & Latest Developments
7.6 Assay Genie
7.6.1 Assay Genie Company Summary
7.6.2 Assay Genie Business Overview
7.6.3 Assay Genie Angiotensinogen Monoclonal Antibody Major Product Offerings
7.6.4 Assay Genie Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.6.5 Assay Genie Key News & Latest Developments
7.7 Abbexa
7.7.1 Abbexa Company Summary
7.7.2 Abbexa Business Overview
7.7.3 Abbexa Angiotensinogen Monoclonal Antibody Major Product Offerings
7.7.4 Abbexa Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.7.5 Abbexa Key News & Latest Developments
7.8 Biorbyt
7.8.1 Biorbyt Company Summary
7.8.2 Biorbyt Business Overview
7.8.3 Biorbyt Angiotensinogen Monoclonal Antibody Major Product Offerings
7.8.4 Biorbyt Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.8.5 Biorbyt Key News & Latest Developments
7.9 RayBiotech, Inc.
7.9.1 RayBiotech, Inc. Company Summary
7.9.2 RayBiotech, Inc. Business Overview
7.9.3 RayBiotech, Inc. Angiotensinogen Monoclonal Antibody Major Product Offerings
7.9.4 RayBiotech, Inc. Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.9.5 RayBiotech, Inc. Key News & Latest Developments
7.10 ZodelBiotec Ltd.
7.10.1 ZodelBiotec Ltd. Company Summary
7.10.2 ZodelBiotec Ltd. Business Overview
7.10.3 ZodelBiotec Ltd. Angiotensinogen Monoclonal Antibody Major Product Offerings
7.10.4 ZodelBiotec Ltd. Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.10.5 ZodelBiotec Ltd. Key News & Latest Developments
7.11 Innovative Research
7.11.1 Innovative Research Company Summary
7.11.2 Innovative Research Angiotensinogen Monoclonal Antibody Business Overview
7.11.3 Innovative Research Angiotensinogen Monoclonal Antibody Major Product Offerings
7.11.4 Innovative Research Angiotensinogen Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.11.5 Innovative Research Key News & Latest Developments
8 Global Angiotensinogen Monoclonal Antibody Production Capacity, Analysis
8.1 Global Angiotensinogen Monoclonal Antibody Production Capacity, 2019-2030
8.2 Angiotensinogen Monoclonal Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global Angiotensinogen Monoclonal Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Angiotensinogen Monoclonal Antibody Supply Chain Analysis
10.1 Angiotensinogen Monoclonal Antibody Industry Value Chain
10.2 Angiotensinogen Monoclonal Antibody Upstream Market
10.3 Angiotensinogen Monoclonal Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Angiotensinogen Monoclonal Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Angiotensinogen Monoclonal Antibody in Global Market
Table 2. Top Angiotensinogen Monoclonal Antibody Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Angiotensinogen Monoclonal Antibody Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Angiotensinogen Monoclonal Antibody Revenue Share by Companies, 2019-2024
Table 5. Global Angiotensinogen Monoclonal Antibody Sales by Companies, (K Units), 2019-2024
Table 6. Global Angiotensinogen Monoclonal Antibody Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Angiotensinogen Monoclonal Antibody Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Angiotensinogen Monoclonal Antibody Product Type
Table 9. List of Global Tier 1 Angiotensinogen Monoclonal Antibody Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Angiotensinogen Monoclonal Antibody Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Angiotensinogen Monoclonal Antibody Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Angiotensinogen Monoclonal Antibody Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Angiotensinogen Monoclonal Antibody Sales (K Units), 2019-2024
Table 15. By Type - Global Angiotensinogen Monoclonal Antibody Sales (K Units), 2025-2030
Table 16. By Application ? Global Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Angiotensinogen Monoclonal Antibody Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Angiotensinogen Monoclonal Antibody Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Angiotensinogen Monoclonal Antibody Sales (K Units), 2019-2024
Table 20. By Application - Global Angiotensinogen Monoclonal Antibody Sales (K Units), 2025-2030
Table 21. By Region ? Global Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Angiotensinogen Monoclonal Antibody Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Angiotensinogen Monoclonal Antibody Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Angiotensinogen Monoclonal Antibody Sales (K Units), 2019-2024
Table 25. By Region - Global Angiotensinogen Monoclonal Antibody Sales (K Units), 2025-2030
Table 26. By Country - North America Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Angiotensinogen Monoclonal Antibody Sales, (K Units), 2019-2024
Table 29. By Country - North America Angiotensinogen Monoclonal Antibody Sales, (K Units), 2025-2030
Table 30. By Country - Europe Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Angiotensinogen Monoclonal Antibody Sales, (K Units), 2019-2024
Table 33. By Country - Europe Angiotensinogen Monoclonal Antibody Sales, (K Units), 2025-2030
Table 34. By Region - Asia Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Angiotensinogen Monoclonal Antibody Sales, (K Units), 2019-2024
Table 37. By Region - Asia Angiotensinogen Monoclonal Antibody Sales, (K Units), 2025-2030
Table 38. By Country - South America Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Angiotensinogen Monoclonal Antibody Sales, (K Units), 2019-2024
Table 41. By Country - South America Angiotensinogen Monoclonal Antibody Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Angiotensinogen Monoclonal Antibody Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Angiotensinogen Monoclonal Antibody Sales, (K Units), 2025-2030
Table 46. Sino Biological, Inc. Company Summary
Table 47. Sino Biological, Inc. Angiotensinogen Monoclonal Antibody Product Offerings
Table 48. Sino Biological, Inc. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Sino Biological, Inc. Key News & Latest Developments
Table 50. Elabscience Biotechnology Inc. Company Summary
Table 51. Elabscience Biotechnology Inc. Angiotensinogen Monoclonal Antibody Product Offerings
Table 52. Elabscience Biotechnology Inc. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Elabscience Biotechnology Inc. Key News & Latest Developments
Table 54. Wuhan Fine Biotech Co., Ltd. Company Summary
Table 55. Wuhan Fine Biotech Co., Ltd. Angiotensinogen Monoclonal Antibody Product Offerings
Table 56. Wuhan Fine Biotech Co., Ltd. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Wuhan Fine Biotech Co., Ltd. Key News & Latest Developments
Table 58. Biomatik Company Summary
Table 59. Biomatik Angiotensinogen Monoclonal Antibody Product Offerings
Table 60. Biomatik Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Biomatik Key News & Latest Developments
Table 62. MyBiosource, Inc. Company Summary
Table 63. MyBiosource, Inc. Angiotensinogen Monoclonal Antibody Product Offerings
Table 64. MyBiosource, Inc. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. MyBiosource, Inc. Key News & Latest Developments
Table 66. Assay Genie Company Summary
Table 67. Assay Genie Angiotensinogen Monoclonal Antibody Product Offerings
Table 68. Assay Genie Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Assay Genie Key News & Latest Developments
Table 70. Abbexa Company Summary
Table 71. Abbexa Angiotensinogen Monoclonal Antibody Product Offerings
Table 72. Abbexa Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Abbexa Key News & Latest Developments
Table 74. Biorbyt Company Summary
Table 75. Biorbyt Angiotensinogen Monoclonal Antibody Product Offerings
Table 76. Biorbyt Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Biorbyt Key News & Latest Developments
Table 78. RayBiotech, Inc. Company Summary
Table 79. RayBiotech, Inc. Angiotensinogen Monoclonal Antibody Product Offerings
Table 80. RayBiotech, Inc. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. RayBiotech, Inc. Key News & Latest Developments
Table 82. ZodelBiotec Ltd. Company Summary
Table 83. ZodelBiotec Ltd. Angiotensinogen Monoclonal Antibody Product Offerings
Table 84. ZodelBiotec Ltd. Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. ZodelBiotec Ltd. Key News & Latest Developments
Table 86. Innovative Research Company Summary
Table 87. Innovative Research Angiotensinogen Monoclonal Antibody Product Offerings
Table 88. Innovative Research Angiotensinogen Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Innovative Research Key News & Latest Developments
Table 90. Angiotensinogen Monoclonal Antibody Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 91. Global Angiotensinogen Monoclonal Antibody Capacity Market Share of Key Manufacturers, 2021-2024
Table 92. Global Angiotensinogen Monoclonal Antibody Production by Region, 2019-2024 (K Units)
Table 93. Global Angiotensinogen Monoclonal Antibody Production by Region, 2025-2030 (K Units)
Table 94. Angiotensinogen Monoclonal Antibody Market Opportunities & Trends in Global Market
Table 95. Angiotensinogen Monoclonal Antibody Market Drivers in Global Market
Table 96. Angiotensinogen Monoclonal Antibody Market Restraints in Global Market
Table 97. Angiotensinogen Monoclonal Antibody Raw Materials
Table 98. Angiotensinogen Monoclonal Antibody Raw Materials Suppliers in Global Market
Table 99. Typical Angiotensinogen Monoclonal Antibody Downstream
Table 100. Angiotensinogen Monoclonal Antibody Downstream Clients in Global Market
Table 101. Angiotensinogen Monoclonal Antibody Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Angiotensinogen Monoclonal Antibody Segment by Type in 2023
Figure 2. Angiotensinogen Monoclonal Antibody Segment by Application in 2023
Figure 3. Global Angiotensinogen Monoclonal Antibody Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Angiotensinogen Monoclonal Antibody Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Angiotensinogen Monoclonal Antibody Revenue, 2019-2030 (US$, Mn)
Figure 7. Angiotensinogen Monoclonal Antibody Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Angiotensinogen Monoclonal Antibody Revenue in 2023
Figure 9. By Type - Global Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 11. By Type - Global Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
Figure 12. By Type - Global Angiotensinogen Monoclonal Antibody Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 15. By Application - Global Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
Figure 16. By Application - Global Angiotensinogen Monoclonal Antibody Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 20. By Region - Global Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
Figure 21. By Country - North America Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 22. By Country - North America Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
Figure 23. US Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
Figure 28. Germany Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 29. France Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
Figure 37. China Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 41. India Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 43. By Country - South America Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
Figure 44. Brazil Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Angiotensinogen Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Angiotensinogen Monoclonal Antibody Sales Market Share, 2019-2030
Figure 48. Turkey Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Angiotensinogen Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 52. Global Angiotensinogen Monoclonal Antibody Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Angiotensinogen Monoclonal Antibody by Region, 2023 VS 2030
Figure 54. Angiotensinogen Monoclonal Antibody Industry Value Chain
Figure 55. Marketing Channels
